MESO - Mesoblast Financial Results and Corporate Update Webcast | Benzinga
NEW YORK, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (NASDAQ:MESO, ASX:MSB)), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and financial results for the fourth quarter and full year ended June 30, 2023.
The webcast will begin at 6.30pm EDT, Wednesday, August 30; 8.30am AEST, Thursday, August 31, 2023. It can be accessed via: https://webcast.openbriefing.com/msb-fyr-2023/
The archived webcast will be available on the Investor page of the Company's website: www.mesoblast.com
About Mesoblast
Mesoblast is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The Company has leveraged its proprietary mesenchymal lineage cell therapy technology platform to ...